UNSPSC 51173209: Bisacodyl/magnesium citrate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA209. This VA Drug Class (GA209) classifies this compound as belonging to the group LAXATIVES, OTHER.

UNSPSC 51173209 Bisacodyl/magnesium citrate is a Commodity code that sees minimal recent state and local procurement activity directly aligned with its nominal scope. The three recent opportunities posted under this code span offender drug testing services, direct-to-manufacturer pharmacy program research, and generic multi-source pharmaceutical distribution through cooperative purchasing — none of which centers on bisacodyl or magnesium citrate products specifically. The code appears to be a categorical placeholder for pharmaceutical product procurement rather than an actively solicited line item, with actual buying activity occurring under broader pharmaceutical family or class codes. When state and local agencies do procure specific pharmaceutical products through this taxonomy tier, they typically request them as part of multi-product lots, bundled pricing agreements, or cooperative-purchasing frameworks that distribute across authorized wholesalers rather than single-product solicitations.

Recent opportunities show issuing-body diversity: Collin County Community Supervision and Corrections Department (Texas) posted an RFP for offender specimen collection and drug testing services due July 23, 2026 with an estimated contract value of $600,000, the Texas Health and Human Services Commission issued an RFI in April 2026 exploring direct-to-manufacturer prescription programs, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products due March 26, 2026, with participation across Minnesota and Oregon. The mismatch between the code's nominal product scope and the actual content of these solicitations — which address testing services, pharmacy program infrastructure, and bulk pharmaceutical distribution — suggests that this Commodity code sees limited real procurement activity for bisacodyl or magnesium citrate products in current state and local markets.